News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Edificio de la sede de Almirall
Almirall launches Act4Impact – its updated sustainability strategy setting ambitious targets for 2030
Healthcare · Climate change
Act4Impact consists of 20 strategic lines of action which will be monitored over time to assess…
Partners - Almirall
Instituto de Investigación, Desarrollo e Innovación en Biotecnología Sanitaria de Elche
IDiBE obtains the renewal of its Scientific Unit for Business Innovation by IVACE+I
Healthcare · Access to innovation
Partners - IDiBE – UMH (Instituto de Investigación, Desarrollo e innovación en Biotecnología Sanitaria)
Médico atendiendo a un paciente en una consulta
How to Leverage Real-World Evidence for Market Access in Rare Disease
Healthcare · Rare diseases
A good way to identify the right data source for a targeted rare disease is to perform a real-world…
Sede de la Organización Mundial de la Salud
AbilityPharma receives WHO approval for its ABTL0812 anticancer drug to be named IBRILATAZAR
Healthcare · Innovative drugs
ABTL0812 has been given the International Non-proprietary Designation (INN) ibrilatazar on the…
Partners - Ability Pharmaceuticals
Fábrica Histokine de Peaches Biotech
Peaches Biotech ready to enter into the production of biological medicines with the Histokine factory
Healthcare · Access to innovation · Innovative drugs · Advanced therapies
The Madrid-based laboratory, together with Histocell and Cardiva, has launched Histokine, located…
Partners - PEACHES BIOTECH S.L.
Mats Sundgren, reconocido experto en Estrategia de Datos de Salud, se une a IOMED como Asesor Científico
Mats Sundgren, a distinguished expert in Health Data Strategy, joins IOMED as Scientific Advisor
Talento · Corporate
Mats brings over 37 years of experience in the pharmaceutical industry, with a career marked by…
Partners - IOMED Medical Solutions SL
Fachada de las oficinas de Oryzon Genomics
ORYZON reports financial results and corporate update for half-year ending June 30, 2024
Healthcare · Access to innovation · Innovative drugs · Advanced therapies
Research and development (R&D) expenses of $4.9m for the half-year ending June 30, 2024. As a…
Partners - Oryzon Genomics
La presidenta del Parlamento Europeo, Ursula von der Leyen
Biotechnology holds a prominent role in the policy directions for the next European Commission 2024-2029
Healthcare · Agrifood · Industrial biotechnology · Financing
The guidelines presented by the President of the European Commission, Ursula von der Leyen,…
Open Innovation Génesis Biomed
What is Open Innovation in pharmaceutical R&D?
Healthcare · Access to innovation · Drug discovery · Innovative drugs
The core idea of Open innovation is that companies leverage the ideas and resources of external…
Partners - GENESIS Biomed